Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X.
Antonios G, Borgers H, Richard BC, Brauß A, Meißner J, Weggen S, Pena V, Pillot T, Davies SL, Bakrania P, Matthews D, Brownlees J, Bouter Y, Bayer TA.
Antonios G, et al. Among authors: bayer ta.
Sci Rep. 2015 Dec 2;5:17338. doi: 10.1038/srep17338.
Sci Rep. 2015.
PMID: 26626428
Free PMC article.